James F. Parslow's Insider Trades & SAST Disclosures
James F. Parslow's most recent trade in Xenetic Biosciences Inc was a trade of 20,000 Stock Options done . Disclosure was reported to the exchange on June 18, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern James F. Parslow.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Xenetic Biosciences Inc | James F. Parslow | Interim CEO and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 20,000 | 20,000 | - | - | Stock Options | |
| Xenetic Biosciences Inc | F. Parslow James | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Dec 2023 | 10,000 | 10,000 | - | - | Stock Options | |
| Xenetic Biosciences Inc | James F. Parslow | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2022 | 50,000 | 50,000 | - | - | Stock Options | |
| Xenetic Biosciences Inc | James F. Parslow | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2021 | 50,000 | 50,000 | - | - | Stock Options |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges